All News

A woman with metastatic breast cancer writes a poem about the dark reality of the disease that hides below the surface.

A certified oncology nurse and board-certified adult nurse practitioner explained how the recent FDA approval of Darzalex Faspro, Kyprolis and dexamethasone may allow patients with relapsed/refractory multiple myeloma to switch treatments after discovering their current treatment is no longer working.

An end-of-life conversation may increase hope in patients with cancer, however many patients may be getting it from oncologists when it’s a “too little too late,” an expert said.

The combination of Calquence and Rituxan may also be useful during the COVID-19 pandemic as it decreases infusion times and patient interactions, according to an expert.

Findings from a clinical trial showed that adding Keytruda to neoadjuvant chemotherapy in patients with triple-negative breast cancer significantly improved outcomes and was overall safe and tolerable for patients.

A cancer survivor explains how she feels like she’s living inside a nightmare with new COVID-19 variants appearing all the time, making her unable to see her family over the holidays.

When storytelling becomes a part of one’s identity, it can benefit a wide group of people — such as the MPN community — to share a potentially lifesaving message, according to LeVar Burton.

As treatments for NSCLC improve survival, this benefit may be affected by depression and anxiety, which is common in patients with the disease and may require patients to advocate for cognitive behavioral therapy among other approaches.

An oncology social worker, who is also a cancer survivor, describes life lessons learned through work and personal experiences.

There are many cancer clinical trials that patients can enroll in across the United States. Here is a snapshot of some of the more recent ones.

A colleague describes Dr. Nagla Abdel Karim’s exemplary compassion for patients with lung cancer and how she works hard to increase representation in cancer clinical trials.

One male breast cancer survivor explains why he considers his cancer experience an “adventure into the unknown,” where he draws inspiration from every survivor he meets.

A non-Hodgkin’s lymphoma survivor writes about how she chose to approach a stressful doctor’s appointment and how doing whatever helps may look different for everyone.

From the story of HGTV’s “Love it or List it” co-host Hilary Farr’s cancer journey to “Pistol Annies” singer Ashley Monroe ringing the bell after finishing cancer treatment, here’s what’s happening in the cancer landscape this week.

CURE® took a look back at our most-read lung cancer stories from this year.

City of Hope has opened its first-in-human clinical trial for an investigational therapy in patients with advanced breast cancer.

The drug Venclexta may address an unmet need for patients with Waldenström macroglobulinemia via a non-chemotherapeutic, safe and effective treatment option.

The vaccine, which protects patients from seven different strains related to HPV-related cancers, may be considered part of routine oncology care for survivors.

A caregiver writes a poem expressing joy over her daughter’s clean scan results after having had breast cancer in her own version of the 12 Days of Christmas.

On this episode of the “Cancer Horizons” podcast, LeVar Burton sits down with CURE® to talk about the importance of MPN awareness and the power of storytelling in advocacy.

Although the recent FDA approval of Keytruda was exciting for high-risk, nonmetastatic renal cell carcinoma, an expert from The University of MD Anderson Cancer Center notes more work is needed, particularly when it comes to individualizing treatment.

Here’s a look back at CURE®’s top-performing melanoma content from the year 2021.

Treatment with the CAR-T cell therapy ciltacabtagene autoleucel (cilta-cel) led to a 97.9% response rate at two years in patients with relapsed/refractory myeloma in a recent clinical trial.

A man who has spent five years dealing with cancer shares his thoughts on the COVID-19 booster shot.

Two different doses of Venclexta combined with Darzalex and the steroid dexamethasone elicited effective responses appeared safe in patients with t(11;14) relapsed/refractory multiple myeloma.

The addition of a drug commonly used to treat arthritis may reduce the risk of graft-versus-host-disease in patients who underwent haploidentical allogeneic stem cell transplant.

Calquence, a next-generation BTK inhibitor, significantly prolonged survival compared with standard of care, along with no new side effects at three years in chronic lymphocytic leukemia. These findings also pertained to some patients with high-risk genetic features.

A pancreatic cancer survivor explains the anguish he felt over seeing a young mother and her child in the waiting room for his oncologist, and what words of advice he would offer her.